Content by The Scientist

John Babich from Ratio Therapeutics explains how radiopharmaceuticals can be designed to better treat cancer, alone and in combination with immunotherapies.

From genetically modified mosquitoes to clinical therapies, learn how scientists apply gene editing techniques to answer a range of important research questions.

As kinase dysfunction underlies many pathological conditions, scientists require high-quality active kinases for their therapeutic development programs.

From ergonomics to automation, learn about the tools that scientists turn to for greater efficiency, accessibility, and sustainability in the lab.

Giovanna Prout from Scale Biosciences discusses the inspiration for and results of the company’s ambitious single-cell sequencing endeavor.    

The TREM2 receptor may hold the keys to understanding how myeloid cells affect immune responses to neurological disorders and cancer.

New PCR-based approaches simplify molecular testing for health issues in infants, making diagnostic approaches simpler and more accessible across laboratories.

The latest group of winning technologies has a little something for everyone—from scientists at the lab bench to those in the clinic and even the classroom.

Julia Swavola from Cerillo explains how an off-the-shelf co-culture system helps researchers shed light on microbial populations in real time.

High-throughput sequencing technology supports mangrove protection efforts.

Multi-tissue dissociation kits provide a versatile and robust solution for streamlining single-cell dissociation workflows.   

Explore how researchers use organoids to understand tissue regeneration and develop novel therapies.

Discover how spatial transcriptomics and proteomics advance wound healing research.

Emmanuel Naouri from Illumina discusses recent innovations that promise to support new and established next-generation sequencing (NGS) users.

As the demand for viral vectors rises in new gene therapy approaches, scientists seek ways to optimize their production.